Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:ceo |
Steven A. Shallcross
|
| gptkbp:clinical_trial |
multiple ongoing studies
|
| gptkbp:focus |
developing therapeutics for microbiome-related diseases
|
| gptkbp:founded |
gptkb:2011
|
| gptkbp:headquarters |
gptkb:Rockville,_Maryland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synthetic Biologics, Inc.
|
| gptkbp:partnership |
various pharmaceutical companies
|
| gptkbp:research_areas |
gptkb:item
|
| gptkbp:symbol |
SYN
|
| gptkbp:traded_on |
gptkb:NYSE_American
|
| gptkbp:bfsParent |
gptkb:SYN-004
|
| gptkbp:bfsLayer |
6
|